This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.
“There were times when I was told you couldn’t even use ‘cannabis’ and ‘research’ in the same sentence,” he recalled. which is conducting millions of dollars worth of research on the use of cannabis to treat conditions including anxiety, insomnia and pain. The federal government is investing in marijuana research too.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.
However, new research has found that psychedelic use is only “weakly associated with psychosis-like symptoms.” New Research Published on Serotonergic Psychedelic Use and Psychosis. New Research Published on Serotonergic Psychedelic Use and Psychosis. The research team under the leadership of Alexander V.
This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies.
This article explores the history of medical marijuana in Ohio, analyzes the changing attitudes and acceptance, and delves into the impact of stigma on its journey to legalization. Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views.
Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).
The talks will be made public, open-access on YouTube two weeks after the event. Session 1: The Shulgin’s Pioneering Psychedelic Research (12:00 PM-2:00 PM PDT). Moderator: Bob Jesse – researcher, engineer, convener of the Council on Spiritual Practices. Click the provided links to reserve a place. Saturday, June 26, 2021.
In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Brief history of ALS. Exploring the available research on ALS and cannabinoids.
Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.
West Virginia’s medical marijuana program was established to provide patients with qualifying medical conditions access to medical cannabis as an alternative treatment option. In this guide, we’ll break down everything you need to know to start accessing medical marijuana in West Virginia.
Mr Morris will be advising COMPASS on research related to new psychedelic compounds that could be developed into therapies in areas of unmet mental health need. Mr Morris will be advising COMPASS on research related to new psychedelic compounds that could be developed into therapies in areas of unmet mental health need.
This transaction will enable the firm to deliver further on its mission of providing the broadest portfolio of quality cannabis medicines to patients across the world at the most accessible prices. million within an hour of the crowdfund opening publicly.
But today, thanks to a combination of changing laws and attitudes and a building consensus of scientific research, there’s another, perhaps unexpected option – ketamine. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” ” 8 9.
The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with refractory epilepsy.
In the past few decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and 60s. Date Written: October 23, 2021. war on drugs.
( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed what it believes to be the largest legal natural psilocybin harvest in Canadian history. To access a complete photo gallery of this historic grow, please click here. Penis Envy. Blue Pulaski.
We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.
The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”
Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. But if that doctor has access to information from 40,000 patients it’s a different story. The Upshot.
From the systemic history of racism in the United States, African Americans exclusion from economic opportunities leads to maximizing profits for the White elite (Hirschman, 2019). Qualitative research study designed is concerned with answering the questions as to why a phenomenon is occurring (Giorgi, 1997). Central Research Question.
The service breaks down existing barriers for patients by providing convenient access to a broader range of options through a single source, alongside expert advice and counsel from trusted healthcare professionals. Statistics Canada, accessible at [link] n1/daily-quotidien/191030/ t002a-eng.htm. TORONTO, Dec.
Those with a family history or personal diagnosis of psychosis are particularly at risk for this effect. While research is limited, anecdotal reports suggest that high doses of edible cannabis products can especially induce psychedelic-like spiritual/mystical experiences. Is combining cannabis and shrooms safe?
The board will work on projects like designing the training program for psychedelic facilitators, tracking psychedelic policy development, studying ongoing science related to psilocybin, and making recommendations to lawmakers regarding the bill. People will not have to meet specific qualifications to access care.
By joining forces, PSI will be able to leverage its size and experience to help expand research and development and testing services. California is a critical market in the United States, with a long history of leading innovation and elevating the conversation around national legalization,” said Ben Rosman, J.D.,
The exact causes of IBD are still unknown but risk factors such as age, race, family history, cigarette smoking, anti-inflammatory as well as environmental factors such as where the individual lives. Luckily, Dronabinol can be organically accessed in its botanical form, THC, directly from the plant. .
Results from a variety of research studies in recent years repeatedly show that a customer relationship management (CRM) strategy can have a significant positive effect on sales, marketing, customer service, and more. . For example, Nucleus Research discovered that the average return on a company’s CRM investment is $8.71
Through an examination of existing research and anecdotal evidence, we aim to provide a closer look at the potential effects of medical marijuana on women’s health. Research suggests that cannabinoids may have anti-inflammatory and analgesic effects, potentially aiding in symptom relief.
On June 30th, the Petrie-Flom Center announced the launch of a three-year research initiative , the Project on Psychedelics Law and Regulation (POPLAR) , which is supported by a generous grant from the Saisei Foundation. POPLAR will publish original law and policy research. What barriers exist to conducting psychedelics research?
While cannabis likely began in the Himalayan region, it spread in our early human history and was found all over the world in different natural environments where it had evolved into different varieties of cannabis – the landrace strains. They may decide this based on its genetic history, its effect profile, or numerous other factors.
It is working to provide the critical infrastructure needed to develop and deliver breakthrough mental health treatments. As a collective enterprise, Ketamine One is dedicated to helping solve the growing need for safe and accessible mental health therapy. The recent addition of KGK Science Inc. The recent addition of KGK Science Inc.
The service breaks down existing barriers for patients by providing convenient access to a broader range of options through a single source, alongside expert advice and counsel from trusted healthcare professionals. Statistics Canada, accessible at [link] n1/daily-quotidien/191030/ t002a-eng.htm. TORONTO, Dec.
To drive brand awareness of, and access to, HaluGen’s Psychedelics Genetic Test Kit. This is just one of many steps we plan to take as we work to develop channels for the commercial development of HaluGen’s Psychedelics Genetic Test,” said Entheon Biomedical Chief Executive Officer, Timothy Ko.
It has shown effectiveness in helping individuals develop better sleep habits and manage insomnia symptoms without relying on medication. Medical marijuana may also interact with other medications, and its use may be contraindicated in individuals with certain medical conditions or a history of substance abuse.
It is only in recent human history, that this mighty herb fell victim to human greed and was bound into the chains of prohibition. ” CBD may be easier for patients to access when they opt to start treatment with medical cannabis. Charlotte went from experiencing a massive 50 convulsive seizures each day, to only 2-3 per month.
Researchers summarized five key points from the 2020 review : * We estimate that more than 2 million U.S. The researchers also noted: When reported, marijuana use has often been self-reported, and few have collected “doses” or blood levels. Instead, the study can be seen as a starting point for discussion and further study. Arrhythmia.
VANCOUVER — Doctors with opposing views on whether medical marijuana should be prescribed for various conditions agree on one thing: their profession is ill-prepared to deal with patients asking for a drug that lacks adequate clinical research. “It’s a tough situation. Follow @CamilleBains1 on Twitter.
Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. A Push by Patients.
Cannabis has a complicated history in the United States. however, and the evolution of the cannabis industry has an interesting history spanning thousands of years and dozens of countries. however, and the evolution of the cannabis industry has an interesting history spanning thousands of years and dozens of countries.
Connection between cannabis use and psychosis The connection between cannabis use and psychosis has been a topic of much research and debate. Studies have shown that individuals who use cannabis are at an increased risk of developing psychotic symptoms. A family history of psychosis also adds to the risk.
She is a mother, activist, artist and NADA acupuncture practitioner focused on developing substance abuse and post-trauma treatment programs for communities in need. It’s shocking, and what’s more, is that the authorities feel justified because it is illegal and don’t care what evidence is out there about its history here.
. “If a small number of companies secure wide swaths of intellectual property early on, then the beneficial impact of that shift may be blunted,” warn researchers. Patents on Psychedelics: The Next Legal Battlefront of Drug Development. Read more at [link]. Harvard Law Review Forum, Vol. 135, 2022 (Forthcoming).
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content